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TransporterThe 18 kDa protein TSPO is a highly conserved transmembrane protein found in bacteria, yeast, animals and
plants. TSPO is involved in a wide range of physiological functions, among which the transport of several mole-
cules. The atomic structure ofmonomeric ligand-boundmouse TSPO in detergent has been published recently. A
previously published low-resolution structure of Rhodobacter sphaeroides TSPO, obtained from tubular crystals
with lipids and observed in cryo-electron microscopy, revealed an oligomeric structure without any ligand.
We analyze this electron microscopy density in view of available biochemical and biophysical data, building a
matching atomic model for the monomer and then the entire crystal. We compare its intra- and inter-
molecular contacts with those predicted by amino acid covariation in TSPO proteins from evolutionary sequence
analysis. The arrangement of the ﬁve transmembrane helices in a monomer of our model is different from that
observed for the mouse TSPO. We analyze possible ligand binding sites for protoporphyrin, for the high-
afﬁnity ligand PK 11195, and for cholesterol in TSPOmonomers and/or oligomers, and we discuss possible func-
tional implications.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Translocator protein (TSPO) is a transmembrane protein that is found
from bacteria to mammals [1]. The mammalian formwas ﬁrst described
in 1977 as a pharmacological target of benzodiazepine diazepam in the
kidney [2], and thus named peripheral-type benzodiazepine receptor. It
exhibits features distinct from the central nervous system benzodiaze-
pine receptor GABAA. Since its discovery, TSPO has been shown to beinsen),
iano.ostuni@inserm.fr
t),present in most tissues and primarily localized in the mitochondria.
However, its function is not yet fully understood since it changes from
bacteria to mammals [1]. It plays an important role in many mitochon-
drial functions frombiogenesis to respiration and is involved in apoptosis
[3]. In particular, TSPO participates in the transport of molecules across
mitochondrial membranes, such as the import of cholesterol, which
is the rate limiting step of steroid and bile salt synthesis [4]. In bacteria,
TSPO has been shown to transport intermediates of the porphyrin
biosynthesis pathway [5] and/or to catalyze the degradation of PPIX
with the consumption of oxygen [6], as well as to regulate virulence ac-
tivity [7].
Until recently, little was known about the three-dimensional struc-
ture of TSPO. First studies were designed to characterize transmem-
brane domains by a topological approach [8] that were later on shown
to be alpha helices [9]. The ﬁrst atomic structure of mouse TSPO was
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highly ﬂexible structure that could only be stabilized by a high-afﬁnity
drug ligand, PK 11195. In contrast, a previous low resolution three-
dimensional structure of bacterial TSPO from Rhodobacter sphaeroides
in lipids was obtained by cryo-electronmicroscopy (cryo-EM) of helical
crystals in the absence of any ligand [11]. It reveals that monomers
consisting of ﬁve transmembrane helices associate to form a homodimer
with the dimer interface involving three helices of eachmonomer. How-
ever, helix–helix connectivity within a monomer was not analyzed by
the authors. There have been various attempts to build atomic models
to ﬁt this cryo-EM density, either using Rosetta modeling [12], or by
homologymodeling based on the recently solved ligand-bound structure
of the mouse orthologue [13]. The dimeric structure raises several ques-
tions about the functional unit and the transport mechanism. Another
arrangement of TSPO has been proposed for the mouse orthologue
from EM images, suggesting an association of three to four monomers
[14,15].
In the present work, we build a polymeric structure for bacterial
ligand-free TSPO in lipids based on the cryo-EM density 3D map
(EMDB entry: 1698). We carefully analyze the densities, isolate mono-
mers and individual transmembrane helices, characterize the connec-
tions between these helices, and build a complete model ﬁtting the
EM density [16,17]. We generate contact predictions using several
programs and analyze the monomer as well as the polymeric associa-
tion of TSPO observed in the crystal. We explore different transmem-
brane arrangements suggested by previously published models [12,13,
18,19]. Finally, we use our model to analyze the ligand binding sites
and possible transport mechanisms in line with available biochemical
data [7,20–25].
2. Material and methods
2.1. Electron microscopy data
We use EMDB entry 1698 [11], which is an electron microscopy
density map for a helicoidal crystal of TSPO from R. sphaeroides. The
coordinates given in the text refer to the grid points of this density
whose spacing is 1.2 Å. The origin of the coordinates is located in the
center of the tube.
2.2. Visualization software
For visualizing the electron microscopy data and identifying the
helices and their connectivity, we used version 1.7 of the molecular
visualization software Chimera [26].
2.3. Coarse-grain molecular dynamics
A homology model of bacterial TSPO (referred as homol_b-TSPO
in the following) was constructed using Modeller version 9.11 [27]
with the ﬁrst of models of the NMR structure as the template struc-
ture (PDB ID: 2MGY). The target–template alignment was based on
the alignment given in Fig. 4. 100 models were generated and the
model with the highest DOPE score was selected. Coarse-grained
(CG) Molecular Dynamics (MD) simulations of homol_b-TSPO and
mouse TSPO were performed in a lipid box. We followed the protocol
for CG membrane protein simulations described in [28], using the
Gromacs 4.5.6 package. The homol_b-TSPO was embedded in a POPC
membrane, solvated, and neutralized by the addition of chloride
counter ions. The Martini 2.2 force ﬁeld [29] was used for the protein,
the membrane and the solvent. The box size was ﬁxed to 15 nm in all
directions. For the bacterial (respectively mouse) sequence, the system
included 699 (700) POPC molecules, 18,702 (18,674) water molecules
of type W, and one chloride ion (4 chloride ions). As recommended
[28], we replaced roughly 5% of the water molecules by 821 (900)
freeze-type water molecules. The secondary structures were analyzedprior to the simulation with the DSSP software (version DsspCMBI)
[30] and restrained during the simulations, as required for the Martini
force ﬁeld. The systems were ﬁrst minimized for 200,000 steps using a
steepest descent algorithm, and then equilibrated for 20ns. The integra-
tion time step was ﬁxed to 20 fs. For equilibration, the system was
coupled to a Berendsen thermostat at T = 310 K with 4.0 ps coupling
time, and to a semi-isotropic Berendsen barostat at 1 bar (coupling
time 4.0 ps and compressibility, 1 × 10−5 bar−1). A shift function was
used for the non-bonded interactions. The cutoff distance was ﬁxed to
1.2 nm and 0.9 nm for Coulomb and van derWaals interactions, respec-
tively. The pair list was updated every 10 steps. The dielectric constant
was set to 15. For the 1 μs production period, a V-rescale algorithm
was used for the thermostat (1 ps coupling time) and a semi-isotropic
Parrinello–Rahman barostat for the pressure (coupling time 12 ps and
compressibility, 3 × 10−4 bar−1).
Four protein structures were selected (every 200 ns) along the
simulation and an all-atom model was constructed for each of them
using a backward protocol recently developed by Tieleman's group
[31]. The Amber force ﬁeld was chosen for the reconstruction. The pro-
tocol parameters were the default ones.
2.4. Construction of the atomic model for TSPO
An initial ideal-helix structure was generated from the primary
sequence using PyMOL [32]. The helix pairs TM2–TM3 and TM4–
TM5, which have the shortest loops, were folded usingMolecular Dy-
namics (MD) simulations performed with the Molecular Modeling
Toolkit [33] using the Amber99-SB force ﬁeld [34]. The system was
simulated in vacuum. The simulation protocol starts with 50 steps
of steepest-descent minimization. The subsequent MD runs use a
Velocity-Verlet integrator, a time step of 1 fs, and distance con-
straints that keep all Cα–Cα distances in each of the two helices
rigid. Atom velocities were initialized randomly from a Gaussian distri-
bution corresponding to a temperature of 50 K, and 10,000 MD steps
were performed for equilibration. After that, a harmonic distance re-
straint was added between the ﬁrst and the last Cα atom in each two-
helix domain. Its force constant was 200 kJ/mol, and the target distance
varied from 4 nm initially to 1.5 nm by steps of−0.5 nm. Each time the
target distance was changed, 5000 steps of MD were performed. The
protocol was run several times with different initial velocities in order
to obtain multiple structures from which we chose the one that best
ﬁtted the EM density.
The TM2–TM3 and TM4–TM5 assemblies thus generated and
the unmodiﬁed TM1 structure were placed by hand into the EM
density. The loops linking the helices were generated using Modeller
version 9.10 [27]. The Molecular Modeling Toolkit was used again
for constructing multimers using the symmetry of the helicoidal
crystal, and for further reﬁnement with respect to the electron
density map. The reﬁnement consisted of an annealing protocol
based on MD runs in which the Amber99-SB force ﬁeld was comple-
mented with an energy term proportional to the EM density map,
during which the crystal symmetry of the assembly was regularly
enforced.
The orientation of the helices was compared to the predictionsmade
using the LIPS method (LIPid-facing Surface) [35].
2.5. Evolutionary correlation detection methods
We used two multiple sequence alignments (MSA). The ﬁrst one
is the 917 sequence MSA that was used to establish the structural
model of TSPO by Evfold [18], the only difference being that we
moved the bacterial TSPO sequence to the top of the alignment.
The second MSA, containing 600 sequences, was obtained using
HMMer3 [36] with the bacterial TSPO sequence as a query. To identify
co-evolution in TSPO, we tested ﬁve methods: CAPS [37,38], CMAT
[39], PSICOV [40], MIBP [41], and Evfold [42]. Taken together, these
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Fig. 1.Dimeric arrangements of the transmembrane helices in various bacterial TSPOmodels
ﬁtted into the cryo-EM density map. (A) and (B) Best ab-initio models (90–5 and 60–9, re-
spectively) fromHopf and collaborators [18]. (C) Best homodimer model from Jaremko and
collaborators [13] built using mouse TSPO atomic structure as a template.
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were ﬁrst ﬁltered to account for the helical properties of the TMs and
their relative orientation deduced from a crude 2D topology. Based on
the location of the TM helices and the loops deduced from TM predic-
tion (Fig. 4), we removed all coevolution pairs between amino acids
within the same helix (intra-helix) or within the same loop (intra-
loop). Moreover, the relative orientation of TM helix pairs from Ncap
to Ccap (Fig. 5), i.e. TM1 antiparallel to TM2, TM2 antiparallel to TM3
etc., implies that some amino acids are far away, e.g., Ncap residues of
TM1 with respect to Ncap residues of TM2. We assumed that these res-
idues would not interact.
Hence, the ﬁlter consisted in considering two co-evolved residues n
and p belonging to helices TMa and TMb, respectively:
2.6. Distances and scoring from coevolution methods
Wecompared ourmodel constructed to ﬁt the EMdensity to bacterial
models generated by homology from the human TSPO models provided
in the supplementary material of Hopf and collaborators [18]. We exam-
ined the correspondence between scoring values and distance distribu-
tion in the monomeric models.
In the bacterial models, we calculated the distances for all pre-
dicted coevolutionary pairs (8420 and 6435 for 600 and 917 se-
quences, respectively). Among these pairs, we selected those with
Cα–Cα distances below 10.5 Å (623 and 607 for 600 and 917 se-
quences, respectively). We analyzed the EVFold scores of these
pairs and found a weak correlation, with only 127 and 138 (for 600
and 917 sequence, respectively) predicted coevolutionary con-
straints being in the 10.5 Å range and having a high score (among
the top 5000). For the bacterial model constructed from the EM den-
sity, we examined the same set of predicted coevolutionary pairs
(8420 and 6435 for 600 and 917 sequences, respectively). We select-
ed the pairs with Cα–Cα distances below 10.5 Å (701 and 792 for 600
and 917 sequences, respectively). Among them, the correlation be-
tween scores and distance distribution was also weak, with only
140 and 144 (for 600 and 917 sequence, respectively) predicted co-
evolutionary constraints having a high score. For all of the models
described above, only 20% of the predicted pairs with the highest
EVFold scores correspond to close contacts in the structure. Similar
conclusions were obtained using the PSICOV method.
3. Results
3.1. Rigid ﬁtting of atomic models into the EM density map
A ﬁrst attempt at ﬁtting atomicmodels into the EM density has been
described in [12], using the two best-scoring models proposed by theRosetta software. These two models respect the helix arrangements
within the monomer and the dimer that were previously suggested in
[11]. They differ from each other in having opposite orientations relative
to the membrane plane (Fig. 1A and B) [12]. A second attempt to ﬁt the
EM density [13] assumed that the tertiary and quaternary structures of
bacterial and mammalian TSPO are the same (Fig. 1C) and were built
using the mouse TSPO atomic structure [10]. Several models were gen-
erated in this work, constructed as dimers using molecular modeling
techniques, and then ﬁtted rigidly into the EM density. The models dif-
fer in their dimer interfaces, the best one by the authors' criteria having
a dimer interface consisting of two TMs. None of themodels respects all
the constraints of the EMdensity,which in particular indicates a dimeric
interface made of three helices. The assembly of multiple dimers into a
ring and the stacking of rings to form the tubular crystal is not reproduced
either by these models.
We built a homology model for bacterial TSPO based on the NMR
data [10] which we then placed into the crystal with TM3, TM4 and
TM5 at the dimer interface. However, we were unable to place correctly
all the TMs formainly two reasons: (i) the compactness of the structure,
which prevents a good simultaneous ﬁt of all the TMs, and (ii) the loca-
tion of TM1 in between TM2 and TM3 (Fig. 1C), which seems to prevent
a correct positioning of these TMs because of the shortness of connec-
tion between TM2 and TM3 in bacteria. It has to be recalled that the
NMR structure was solved in detergent with PK 11195, a high afﬁnity
ligand bound in a hydrophobic pocket in the middle of the ﬁve TMs,
which stabilizes the structure. In the absence of a ligand, the TSPO struc-
ture is much more ﬂexible [10,15]. We have performed coarse-grained
molecular dynamics (CG-MD) in a lipid environment to check if protein
ﬂexibility could improve the ﬁt to the EM density. After 1 μs the struc-
ture without ligand shows largemovements of the TMswith the largest
movement observed for TM1, but none of the selected conformations
along the CG-MD simulation trajectory improves the quality of the ﬁt
into the EM density. We also performed CG-MD of the dimer in a lipid
environment, with no better results. We thus started from the EM
density to build a new atomic model, with the goal of respecting all
the crystal constraints.
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Fig. 2. Cryo-EM densitymap of bacterial TSPO at 2.0σ. (A) Side view showing the densities
outside of the membrane. The two red cylinders correspond to the top and bottom of the
membrane and are separated by 35 Å. (B) Top view showing the structure of the crystal as
a stack of rings of dimers. The rings are separated by black lines. Two individualmonomers
are colored in red and green. Densities extruding from themembrane plane are labeled as
χ symbol within a ring and as dotted circle between adjacent rings.
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Fig. 2A shows the cryo-EM3Ddensitymap for bacterial TSPO (EMDB
entry: 1698), with the upper and lower limits of a membrane of 3.5 nm
thickness indicated by red cylindrical surfaces. Few densities appear
above and below the membrane. The cylinder is formed of stacked
rings (Fig. 2B) containing twelve TSPO homo-dimers each [11]. Among
the densities extruding from the membrane plane, some belong to the
ring (χ symbol) but others join two adjacent rings (dotted circle). Two
monomers have been selected in one of the rings for further analysis,
and are shown colored in green and red (Fig. 2B).
Looking at planes parallel to the membrane in these two monomers
(Fig. 3), we observe, as mentioned by Korkhov and collaborators [11],
isolated densities that are easily attributed to transmembrane helices
in the middle of the membrane (Fig. 3B). However, this attribution is
more difﬁcult when looking at planes above and below (Fig. 3A and C,
respectively). We placed colored spheres (one color per helix) of corre-
sponding size on each density in the central plane and checked continuity
on the planes above and below to follow the connections needed to con-
struct a 3D model (Fig. 3D).
In order to build an atomic model, we ﬁrst analyzed the primary
sequence alignments of bacterial and animal TSPO (Fig. 4) to locate
the amino acid sequences of the individual transmembrane helices.
Careful attention was given to residues usually placed at the membrane
interface, such as tryptophan residues [43]. It has been veriﬁed previ-
ously from NMR data [9] that peptides corresponding to putative trans-
membrane helices of mouse TSPO were indeed structured into helices,
an observation that was recently conﬁrmed by the full atomic struc-
ture [10]. Connectivity between transmembrane helices in the densitieshas been assumed where spheres in one plane tend to overlap. Differ-
ences in the lengths of the loops, as well as for the N- and C-termini,
have also been taken into account in our assessment of connectivity.
Indeed, the C-terminus is longer than the N-terminus since it contains
the polyhistidine tag [11]. The longest loop (loop 1) is located between
the ﬁrst (TM1) and the second (TM2) transmembrane helices and faces
the cytosol, like the C-terminus. There is only one place in the density
map that can accommodate this long loop between TM1 and TM2
(Fig. 5A): it corresponds to the largest density (χ symbol) that protrudes
outside the tube (Fig. 2). The assignment of TM2 to the yellow spheres
was motivated by the proximity between yellow and orange spheres
(Fig. 5B), which is constrained by the very short loop (loop 2) between
TM2 and TM3 (Fig. 4). The green spheresmust then correspond to TM1,
which is conﬁrmed by the small density that protrudes inside the tube
(Fig. 2) and that could match with the N-terminus. The assignment of
the three ﬁrst TMs is thus green, yellow and orange spheres for TM1,
TM2 and TM3, respectively. The identiﬁcation of the red spheres with
TM5 is supported by the protruding density (dotted circle) on the
outer surface of the tube (Fig. 5C), which could match the C-terminus
polyhistidine tag, as previously suggested by Korkhov and collaborators
[11]. This leaves the blue spheres as representing TM4, in agreement
with the connectivity with the orange spheres (Fig. 5D) that matches
loop 3 between TM3 and TM4. The ﬁnal complete attribution (Fig. 5E)
is green, yellow, orange, blue and red spheres for TM1, TM2, TM3,
TM4 and TM5, respectively. We note that the geometrical arrangement
of the ﬁve TMs in the density (Fig. 6A and B) resembles the description
provided by Khorkov and collaborators [11].
3.3. Atomic model construction
As a ﬁrst step in building an atomic model, we constructed a linear
helix structure of bacterial TSPO from the sequence using the PyMOL
program [32]. This structure is almost a single ideal helix, kinked only
by some proline residues. We cut this linear structure into three
domains TM1, TM2–TM3 and TM4–TM5, using the deﬁnition of the
transmembrane domains shown by the boxes in Fig. 4. The reason for
grouping TM2–TM3 and TM4–TM5 into two-helix domains is the short-
ness of the loops connecting these pairs, which imposes severe con-
straints on their relative position. The TM1 model has a bend at Pro 18
that corresponds well to a kink in the density. TM2–TM3 and TM4–TM5
were folded using Molecular Dynamics simulations with distance con-
straints on all pairs of alpha carbons within each transmembrane helix.
With the constraints maintaining the geometry of the individual helices,
the two-helix segments reliably fold into a compact structure in which
the helices are nearly antiparallel. Multiple models were generated by
starting the simulationwith different randomly assigned initial velocities,
leading to slightly different relative orientations of the helices. They were
placed into the electron density map to select the best ones (Fig. 6A and
B). The vertical placement of the TM helices was veriﬁed by looking at
the residues located near the membrane interface. The orientations of
the TM helices were validated by comparing their hydrophobic vectors
to predictions of the lipid-facing surfaces made using the LIPS software
[35]. For this step, sequences of two bacteria, two archaeabacteria and
six animal species (including R. sphaeroides and mouse, respectively, for
EM and NMR data) were aligned and the predicted transmembrane
helices (shown as boxes in Fig. 4) were used as input for the LIPS server
[44]. A helical wheel cartoon model shows the resulting orientations of
the ﬁve transmembrane helices of TSPO (Fig. 6C). The orientation of
TM1 in our model is not in agreement with the LIPS prediction but we
gave higher priority to aligning the proline-induced bend in the con-
structed structure with the corresponding EM density. The orientation
of the pair TM2–TM3 is in good agreement with the LIPS prediction. For
the TM4–TM5 domain, the simulation protocol outlined above results in
conformations that are credible in the monomer, but leads to clashes
between helices belonging to neighboring monomers when placed into
the crystal.We used the LIPS prediction to identify pairs of residues either
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Fig. 3. Attribution of transmembrane helices. Planes of the cryo-EM density map of bacterial TSPO at 1.95σ, parallel to themembrane plane: (A) Upper plane (211) placed 7.2 Å above the
middle of the membrane, (B) plane 205, corresponding to the middle of the membrane, (C) lower plane (199) placed 7.2 Å below the middle of the membrane. The darker boxes corre-
spond to TSPO dimers. (D) Two adjacent densities forming a dimer (in red and green) with planes positioned at 5 levels (equally spaced at 7.2 Å and distributed from one side to the other
of the membrane plane) have been used to place colored spheres and check continuities between planes.
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(Val106/Ala138) of the two helices, and put harmonic distance restraints
on these pairs in order to get a structure compatible with both the LIPS
prediction and the crystal geometry. This structure was further improved
by a molecular dynamics run with added harmonic restraints that align
the helix axes with the colored spheres from Fig. 3D. The ﬁnal set of TM
(1 to 5) was used to generate a full atomic model, including loops, using
the Modeller software [27,45]. Modeller proposed several models,
which were nearly identical in the helix regions but different in the loop
arrangements. We chose the model whose loops were closest to the EM
densitymap. The two longest loops (TM1–TM2 and TM3–TM4)were fur-
ther optimized by a molecular dynamics run with added harmonic re-
straints that push the loops into positions more compatible with the EM
map. The full TSPO monomer was then duplicated to ﬁll the EM density
with rings of dimers (Fig. 7A). A group of 8 monomers forming 4 dimers
in 2 adjacent rings is shown in Fig. 7A. It was optimized in a subsequent
step by a molecular dynamics run in which the EM density map was
used as an external potential energy term, in order to generate a better
positioning of the proteinswithin the density. Fine-tuning of the loops be-
tween the helices is difﬁcult since the densities corresponding to these
loops are not as well deﬁned as the densities for the helices. Their volumeprobably arises from an average of conformations. The ﬁnalmodel allows
us to visualize contacts between themonomerswithin a ring (Fig. 7B) and
also between rings (Fig. 7C).
3.4. Model validation by coevolution analysis
Amino acid covariation is becoming a powerful tool to predict 3D
contactswithin proteins and protein complexes [46]. It has been applied
to predict structures of TSPO [18], which we have discussed above. We
used coevolution results to assess our model rather than for guiding
its construction. We compared the contacts predicted from coevolution
analysis with the contacts observed in our EM-based model. We tested
different prediction methods and two different sets of sequences (600-
alignment and 917-alignment, see the Material and methods section).
We measured intra- and intermolecular Cα–Cα distances between the
different regions, i.e. TM, loops and N- and C-termini, and sorted them
by ranges of distances (Table 1). When comparing intramolecular dis-
tances with predicted molecular contacts from evolutionary data, the
best agreement (~94%)was obtainedwith the 600-sequence alignment.
The main difference between the two alignments is small and was ob-
served between TM–TM intramolecular regions. We conclude that the
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Fig. 4. Sequence and helix assignment of various TSPO homologues. Boxes depict the aligned amino acid sequences of the various species corresponding to the ﬁve predicted transmem-
brane domains (labeled TM1 to TM5). Red boxes on themouse TSPO sequence correspond to helices in the atomic structure [13]. Numbers on top correspond to Rhodobacter spaheroides
TSPOwhereas numbers at the bottom correspond tomouse TSPO1. Amino acidsmutated in the studies of heme binding [6,23], Ro5-4864 and PK 11195 [20,21] are indicated by stars in the
top line and circled stars in the bottom line, respectively. Amino acids involved in PK 11195 binding in the atomic structure obtained fromNMR data [10] arewritten in red bold characters
in the bottom line. These residues have at least one atom at less than 3 Å from any atom of PK 111195.
573K. Hinsen et al. / Biochimica et Biophysica Acta 1848 (2015) 568–580atomicmodel of themonomer that we constructed to ﬁt the EM density
is globally in agreement with the evolutionary constraints.
When comparing intermolecular distances with predicted molecular
contacts, the agreement is smaller: only ~30% of the TM–TM contacts
are predicted. Evolutionary constraints give fewer intermolecular con-
tacts than those observed in the crystal (342 versus 451 in Table 1). A
mode detailed analysis shows that this difference concerns mainly the
contacts predicted between loops and transmembrane helices. It has to
be noted that the contacts between the loops connecting TM1 and TM2,
which stabilize the crystalline dimer inside a ring, are not predicted,
whereas contacts between dimers in two adjacent rings (monomers 0
and 4 in the diagram of Fig. 8) are predicted. Dimeric interactions inside
a ring are predicted to occur throughmonomers 0 and2, involvingmostly
TM–TM interactions. Taking into account the natural ﬂexibility of loopsand that some crystallographic constraints could not be connected to
evolutionary constraints, we conclude that the crystal assembly that we
constructed to ﬁt the EM density is globally in agreement with intra-
and intermolecular distances predicted by the evolutionary constraints.
4. Discussion
4.1. Comparison to earlier structure predictions
Several atomicmodels of TSPOhave been published previously, con-
structed using various molecular modeling techniques: based on the
apolipoprotein structure [19], from evolutionary constraints [18] for
human TSPO, by ab initio modeling guided by the EM density [12], or
by homology modeling of bacterial TSPO from mouse TSPO [13]. The
BA
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E
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TM2
TM3
TM4
TM5
C-ter (PolyHis)
N-ter 
Top 214
Top 223 Top 217
Bottom 193
Fig. 5. Assignment of transmembrane helices. (A) Top view of plane 214 (10.8 Å above themiddle of themembrane). The green-yellow connectivity shown in gray corresponds to loop 1.
Note that the gray densities on the left and the right are not symmetrical due to the curvature of the tube. (B) Bottom view of plane 193 (14.4 Å below themiddle of themembrane). The
orange-yellow connectivity is shown by overlapping spheres. The gray density protruding from the green spheres corresponds to the N-terminus. (C) Top viewof plane 223 (21.6 Å above
themiddle of themembrane). The gray density protruding from the red spheres corresponds to the C-terminuspolyhistidine tag. (D) Top viewof plane 217 (14.4Å above themiddle of the
membrane). The orange-blue connectivity shown in gray corresponds to loop 3. (E) Colored TSPO model for the attribution of the 5 transmembrane helices.
574 K. Hinsen et al. / Biochimica et Biophysica Acta 1848 (2015) 568–580transmembrane topologies of thesemodels are quite different (Fig. 9). If
we analyze the compatibility of these models with the EM density, the
helix topology of apolipoprotein (Fig. 9A) involves loop crossings that
seem incompatible with the EMdensity. Since no atomicmodel is avail-
able for comparison, we could not explore this further. Similarly, the to-
pology of Hopf and collaborators' [18] model 90_5 (Fig. 9B) does not
match the EM density map. In particular, the shortness of loop 2 (3 res-
idues) is not compatible with the large distance between TM2 and TM3
that is required for ﬁtting the EM density. In the second model (60_9)
proposed by Hopf and collaborators [18], whose helix topology agrees
with the NMR structure for mouse TSPO [10], the positions of TM2
and TM3 combined with the length of loop 2 are not compatible with
the density map (Fig. 9C). Moreover, we could not ﬁnd any EM density
that could accommodate the N-terminus for this model's TM1 location.
There have been two attempts at constructing atomic models for
bacterial TSPO that take into account the EM density. The models
proposed by Li and collaborators [12] have very different TM topolo-
gies (non-sequential positioning of the TMs for the ﬁrst model, andclockwise sequential positioning of the TMs for the second model).
In their ﬁrst model (Fig. 9D), TM5 is at the intra-ring dimer interface,
and TM1 and TM2 are at the interface of dimers between rings. In
their second model (Fig. 9E), the dimers are oriented upside down
compared to their ﬁrst model, with TM1 and TM2 located at the
dimer interface and the long loop 1 facing the interior of the tube,
where it does not ﬁt into any EM density. In neither of these two
models, the density extruding from the tube (Fig. 2A) contributes
to any dimer interface. The dimer models proposed by Jaremko and
collaborators [13] by homology modeling based on the mouse TSPO
NMR structure [10] were constructed by placing two TMs at the
dimer interface, in contradiction to the observation by Korkhov and
collaborators [11] that the dimer interface is formed by three TMs.
More generally, the automated procedures used for constructing
the models discussed above seem to produce models that do not ﬁt
all the EM density for the 3D crystal. Our step-by-step manual ap-
proach, which takes the EM density as its starting point, leads to a
more suitable model.
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Fig. 6. Placement of the transmembrane helices into the TSPO densitymap. (A) Side and (B) top views of the bacterial TSPO helices placed into the cryo-EM densitymap. (C) Helical wheel
cartoons illustrating the predicted lipid exposed faces (outlined with a gray line) of the ﬁve helices (H1 to H5) of the bacterial TSPO. The prediction was obtained by running the LIPS
program on the aligned sequences of the various species shown in the boxes in Fig. 4.
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TSPO based on NMR data [10] and to place it into the crystal with
TM3 to TM5 at the dimer interface raises the question of the TM helix
topology. The placement of TM1 and TM2 in sequential order with the
other helices (Fig. 9F) leads to a much better ﬁt into the EM density.
Such a difference in helix topology can be due to a difference between
bacteria and animals, in spite of a sequence identity between mouse
and R. sphaeroides that is close to 30%. Indeed, the sequence alignment
(Fig. 4) shows a gap between TM2 and TM3 for bacteria compared to
animals. In line with this, it has to be noted that the amino acid
sequence of TM1 is notwell conserved during evolution.Moreover, bac-
teria have a membrane insertion different from mitochondria in that
the ﬁrst loop and the C-terminus face the cytosol rather than thematrix
[7,23]. This may be due to the different location of DNA, which is in the
cytosol of bacteria but in the nucleus of eukaryotic cells.4.2. Analysis of oligomeric contacts in the crystal
The formation of crystals frommembrane proteins requires not only
correctly folded proteins with good intramolecular contacts, but also
stabilization by intermolecular interactions. These interactions can
take the form of TM contacts, but also take place between loops. The
same contacts that stabilize the crystal could also contribute to oligo-
merization in the native membrane.
The present model allowed us to analyze bacterial TSPO crystals in
more depth. It shows that the oligomeric packing of the proteins inside
the3Dcrystals carries valuable information about thedifferent intermo-
lecular interactions that could take place in vivo.
TSPO monomers interact by their large loop connecting TM1 and
TM2, characterized by the large χ-shaped density observed outside
the tubular crystal, which none of the previously proposed models can
CA
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23
Fig. 7. Atomic model for bacterial TSPO in the cryo-EM density. (A) Top and (B) side views of monomers (colored individually) forming rings of dimers. (C) View between rings showing
the C-terminus connecting the rings.
576 K. Hinsen et al. / Biochimica et Biophysica Acta 1848 (2015) 568–580explain. The extended volume occupied by the two loops of two facing
monomers suggests a high ﬂexibility. This also means that our model
is compatible with the formation of covalently bound dimers that are
observed betweenmutated Trp38Cys [23] andwhich are located almost
in the middle of the loop.
On the opposite side of the monomer, TM3, TM4 and TM5 interact
with the same TM's of the adjacent monomer in a ring. The stabilizationof two neighboring rings seems to involve the C-terminal domains of
onemonomer from each ring, characterized by a clear density protrusion
observed at the ring interface. The interaction of twoC termini containing
the polyhistidine tag (His-Cter) could be favored by the presence of ions.
Such a His-Cter_His-Cter stabilization could explain why a previous at-
tempt to crystallize the recombinant mouse TSPO with the polyhistidine
tag attached to the N-terminus did not succeed [14]. The His-Nter
Table 1
Cα–Cα distances between the different domains (TM, loops, N- and C-terminus) of our model ﬁtted to the EM density. Non-TM means loops and terminal domains. “Model”means the
total number of contacts in our atomicmodel, “917 and 600 seqs” refers to the contacts predicted fromevolutionary constraints calculatedwith a set of different programs (see theMaterial
and methods section). The intermolecular contacts are decomposed by pairs of monomers which are numbered as indicated in Fig. 8.
Distance (Å) 5.5 6.5 7.5 8.5 9.5 10.5
Intra-molecular contacts Model TM–TM 23 58 108 195 339 507 843
TM–nonTM 30 73 106 155 226 304
nonTM–nonTM 1 2 10 13 20 32
917 seqs TM–TM 21 54 90 167 292 421 701
TM–nonTM 24 64 94 133 196 259
nonTM–nonTM 1 1 7 9 13 21
600 seqs TM–TM 23 57 102 182 318 457 792
TM–nonTM 30 73 106 155 226 303
nonTM–nonTM 1 2 10 13 20 32
Inter-molecular contacts Models 0–1 TM–TM 0 0 0 0 0 0 176
Models 0–2 TM–TM 0 4 9 28 50 97
Models 0–3 TM–TM 0 0 1 2 2 2
Models 0–4 TM–TM 3 9 17 22 44 73
Models 0–5 TM–TM 0 0 0 0 0 2
Models 0–6 TM–TM 0 0 1 2 2 2
Models 0–1 TM–nonTM 0 0 2 14 16 32 210
Models 0–2 TM–nonTM 0 0 0 0 12 16
Models 0–3 TM–nonTM 0 2 6 12 21 33
Models 0–4 TM–nonTM 4 6 16 32 62 96
Models 0–5 TM–nonTM 0 0 0 0 0 0
Models 0–6 TM–nonTM 0 2 6 12 21 33
Models 0–1 nonTM–nonTM 0 1 4 12 18 26 65
Models 0–2 nonTM–nonTM 0 0 0 2 4 7
Models 0–3 nonTM–nonTM 0 0 0 1 3 4
Models 0–4 nonTM–nonTM 0 0 4 14 16 24
Models 0–5 nonTM–nonTM 0 0 0 0 0 0
Models 0–6 nonTM–nonTM 0 0 0 1 3 4
600 seqs 0–1 TM–TM 0 0 0 0 0 0 96
600 seqs 0–2 TM–TM 0 4 6 12 22 46
600 seqs 0–3 TM–TM 0 0 1 2 2 2
600 seqs 0–4 TM–TM 0 2 8 12 26 46
600 seqs 0–5 TM–TM 0 0 0 0 0 0
600 seqs 0–6 TM–TM 0 0 1 2 2 2
600 seqs 0–1 TM–nonTM 0 0 2 14 16 32 210
600 seqs 0–2 TM–nonTM 0 0 0 0 12 16
600 seqs 0–3 TM–nonTM 0 2 6 12 21 33
600 seqs 0–4 TM–nonTM 4 6 16 32 62 96
600 seqs 0–5 TM–nonTM 0 0 0 0 0 0
600 seqs 0–6 TM–nonTM 0 2 6 12 21 33
600 seqs 0–1 nonTM–nonTM 0 0 0 0 0 0 36
600 seqs 0–2 nonTM–nonTM 0 0 0 2 4 6
600 seqs 0–3 nonTM–nonTM 0 0 0 1 3 4
600 seqs 0–4 nonTM–nonTM 0 0 4 14 16 22
600 seqs 0–5 nonTM–nonTM 0 0 0 0 0 0
600 seqs 0–6 nonTM–nonTM 0 0 0 1 3 4
0
21
3
Fig. 8. Labeling of the TSPOmonomer arrangement within the tubular crystal. The central
monomer (0) is shown in blue, adjacent monomers within a row in green (1) and orange
(2), and monomers from an adjacent ring in red (3).
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terminus is involved in cholesterol binding [22,25].
4.3. Ligand binding sites and TSPO function
We used our atomic model of bacterial TSPO to explore the putative
location of the ligand binding sites. The binding pocket for PK 11195 in
mouse TSPO has been identiﬁed and involves amino acids of all the TMs
and of the TM1–TM2 loop (Fig. 4). In our ligand-free model for bacterial
TSPO, the ﬁve TMs can also form a pocket to bind PK 11195 since some
of the corresponding bacterial residues are also oriented toward the
center of the transmembrane domain. However, displacements of the
helices and rotations around their axes are required for enabling close
interaction with PK 11195. The TM1–TM2 loop that caps the PK 11195
in the mouse TSPO structure is outward-orientated, yielding access to
the pocket (Fig. 10A). This suggests that this loop, which is involved in
dimer interaction in bacteria, will have to move after the entry of PK
11195 into the pocket, or may serve as a guide toward the pocket for
the ligand. Indeed, mutagenesis studies have shown that highly con-
served amino acids present in this loop regulate PK 11195 afﬁnity and
selectivity [1,20–22,47]. Such a mechanism of ligand binding involves
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Fig. 9. Transmembrane helix arrangements in differentmodels. (A)Homologymodel from
Anzini and collaborators [19]. (B) and (C) Best ab initio models (90–5 and 60–9, respec-
tively) from Hopf and collaborators [18]. (D) and (E) Ab initio model 1 and from Li and
collaborators [12], respectively. (F) Our EM-based model.
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Fig. 10. Ligand binding sites of bacterial TSPO. (A) Putative PK 11195 binding mechanism
in the atomic model for bacterial TSPO. Side views (upper panels) and top views (lower
panel) of TSPOwith PK 11195 shown in purple. (B) Putative porphyrin binding and trans-
port (arrows) mechanism in the atomic model of bacterial TSPO. Side views of the mono-
mer (left panel) and polymers (right panel) in a ring of TSPO monomers, with porphyrin
shown as a purple hexagon. (C) Putative cholesterol-hopanoid binding site. Top view of
the polymeric assembly of TSPO showing two individual monomers in two adjacent
rings. Cholesterol or hopanoid molecules are shown as black ellipses at the interface of
two monomers in the region of the C-terminal containing the CRAC (cholesterol recogni-
tion amino acid consensus) motif.
578 K. Hinsen et al. / Biochimica et Biophysica Acta 1848 (2015) 568–580a large rearrangement of the protein, which is in agreement with the
conformational changes observed in CG-MD of mouse TSPO after re-
moving the ligand. The difference in the amino acid sequence of this
loop between bacterial and mammalian TSPO may contribute to the
large observed change in PK 11195 afﬁnity [48–50]. Point mutations
in this loop as well as in the TMs forming the binding site would permit
a better characterization of whatmakes the difference between bacteria
and animals. In particular, amino acids involved in the PK 11195 binding
pocket of the atomic structure of mouse TSPO that are not conserved in
R. sphaeroides are good candidates.
Both porphyrins and PK 11195 have been described to bind to
bacterial TSPO in a way similar to mammalian TSPO [23,48–53]. The
bindings of porphyrins and PK 11195 are exclusive. It has also been
shown that bacterial TSPO is involved in the efﬂux of porphyrin inter-
mediates from the cell [53], suggesting that porphyrin may pass in be-
tween the transmembrane helices of TSPO. Two main hypotheses can
be proposed: (i) Porphyrins and PK 11195 share the same binding site
within the ﬁve TMs, and porphyrins are transported by the TSPOmono-
mer. (ii) The binding sites are different but the presence of one ligand
affects the binding site of the other (Fig. 10B). In the ﬁrst case, the trans-
port of porphyrins, which are larger molecules than PK 11195, could be
accommodated by large amplitude ﬂuctuations of the transmembrane
domain of TSPO. Interestingly, the atomic model proposed here shows
that Trp50 (TM2), which has been observed to be important for the
binding of tetrapyrrols by bacterial TSPO [52], is located in between
the ﬁve TM helices. Conversely, Trp135 (TM5) is facing outside the
central cavity made by the TM helices, in agreement with the absence
of effect upon its mutation [52]. However, we cannot exclude that
porphyrins cross the membrane at the dimer interface as previously
suggested [12]. In this second case, the involvement of the TM1–TM2
loop predicted to participate in the porphyrin binding site [23] would
explain why PK 11195 cannot be bound at the same time. Indeed, the
binding of porphyrinwould prohibit the capping of the PK 11195 binding
pocket. Porphyrin transport would thus occur in between dimers
interacting by their loops rather than dimers interacting by their TM3
to TM5 as previously suggested [12]. The design of point mutations to
test these different hypotheses for porphyrin transport is not an easy
task. Aromatic residues in the putative channel formed by the ﬁve TM
could be a ﬁrst target. Aromatic residues present at the interface between
dimers and in particular those of TM3 and TM4 placed at the bacterial
TSPO interface could be a second one.It has been suggested that bacterial TSPO may transport hopanoid
[54] instead of cholesterol as in mammalian species [1]. Transport of
cholesterol in animals clearly involves the CRAC domain (L/V/I-(X)
1–5-Y-(X)1–5-R/K) located at the terminal part of TM5 [22,25]. Our
atomic model suggests that this domain could face the lipid rather
than the central region of the TSPO, in agreement with previous studies
showing that mammalian TSPO could transport either membrane-
resident cholesterol or cholesterol coming from external sources [55,
56]. Our model also shows that this motif is located at the interface of
two rings in the crystal, which is stabilized by C-terminus interactions
[11]. Such dimer interactions, different from the intra-ring dimers
mentioned previously for porphyrins, raise the question of cholesterol–
hopanoid transport. The TSPO-cholesterol stoichiometry has been previ-
ously determined to be one to one [57–59]. One may thus suggest that
two cholesterol molecules are face to face in between the dimer as pre-
viously described [60]. The cholesterol pathway through themembrane
remains to be determined; it might involve protein–protein interfaces
[55,61] or the central region of TSPO. Whatever the mechanism, the
579K. Hinsen et al. / Biochimica et Biophysica Acta 1848 (2015) 568–580two sites for cholesterol and the activating ligand are structurally dis-
tinct, since the binding of one does not preclude the binding of the
other [22,25].
In conclusion,we propose amodel for bacterial TSPO in a lipid crystal
environment that shows a different topology than that observed for
ligand-bound mouse TSPO in detergent, and also different oligomeric
contacts compared to previously proposed models. Importantly, this
model satisﬁes all the crystallographic constraints. Interestingly, the
monomer is compatible with the high ﬂexibility of the protein, as evi-
denced by NMR data [9,10]. It may suggest signiﬁcant conformational
changes that could occur during the PK 11195 binding due to trans-
membrane rearrangement and the ﬂexibility of the long connecting
loop between TM1 and TM2. The oligomers within and between rings
give clues to understand the binding and transport of prophyrin and
cholesterol.
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